Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns
- 31 July 2007
- journal article
- review article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 60 (7), 651-657
- https://doi.org/10.1016/j.jclinepi.2006.10.020
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Some issues with composite endpoints in clinical trialsFundamental & Clinical Pharmacology, 2005
- Key Issues in End Point Selection for Heart Failure Trials: Composite End PointsJournal of Cardiac Failure, 2005
- Composite Outcomes in Randomized TrialsJama-Journal Of The American Medical Association, 2003
- Clinical Trials—Multiple Treatments, Multiple End Points, and Multiple LessonsJama-Journal Of The American Medical Association, 2003
- Combined endpoints: can we use them?Statistics in Medicine, 2002
- Statistical principles for clinical trials (ICH E9): an introductory note on an international guidelineStatistics in Medicine, 1999
- Discussion: Some issues in the construction and use of clusters of outcome eventsControlled Clinical Trials, 1997
- Clinical perspectives on the use of composite endpointsControlled Clinical Trials, 1997
- An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point.Circulation, 1992
- A method of assigning scores to the components of a composite outcome: An example from the MITI trialControlled Clinical Trials, 1992